Literature DB >> 9112222

Epitope analysis of chromo antigen and clinical features in a subset of patients with anti-centromere antibodies.

Y Muro1, T Yamada, T Iwai, K Sugimoto.   

Abstract

Heterochromatin protein 1 (HP1) is one of the nonhistone chromosomal components tightly associated with the pericentromeric heterochromatic region in Drosophila. The human homologue of HP1 is recognized by a subpopulation of anti-centromere antibodies (ACA). Such autoantibodies recognize a group of several nuclear proteins with Mr of 23-25 kDa and have been termed 'anti-chromo antibodies (AChA)' because an evolutionarily conserved N-terminal half called the 'chromo domain' of HP1 is the epitope. In this study, 84 ACA sera were examined by immunoblotting with recombinant 25-kDa chromo protein (p25). The p25 antigen was expressed as a glutathione S-transferase-fusion protein in E. coli and purified with glutathione-sepharose. Except for one serum specimen, AChA-positive sera reacted with the N-terminus (a.a 16-106) and/or the C-terminus (a.a. 83-191) of p25. Autoimmune response against the N-terminus of p25 in 33 patients was significantly associated with systemic lupus erythematosus and significantly related to leukopenia, thrombocytopenia and elevated erythrocyte sedimentation rate; C-terminal reactivity in 30 patients was significantly associated with primary Sjogren's syndrome and related to leukopenia. The internal 64-amino acid stretch (a.a 43-106) with DNA-binding activity was not autoantigenic. p25 has two separate homologous regions to Drosophila HP1 at the N- and C-termini; the chromo domain and the chromo shadow domain. Patients with autoimmune response against these conserved domains might form a clinical subset of patients positive for ACA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9112222     DOI: 10.1007/bf00351162

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  18 in total

1.  The heterogeneity of anticentromere antibodies in immunoblotting analysis.

Authors:  Y Muro; K Sugimoto; T Okazaki; M Ohashi
Journal:  J Rheumatol       Date:  1990-08       Impact factor: 4.666

2.  The chromo superfamily: new members, duplication of the chromo domain and possible role in delivering transcription regulators to chromatin.

Authors:  E V Koonin; S Zhou; J C Lucchesi
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

3.  Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.

Authors:  W Earnshaw; B Bordwell; C Marino; N Rothfield
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

4.  Frequency and clinical associations of anti-chromo antibodies in connective tissue disease.

Authors:  E Soriano; J Whyte; N J McHugh
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

5.  Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease.

Authors:  N J McHugh; I E James; P J Maddison
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

6.  Clinical features of anti-chromo antibodies associated with anti-centromere antibodies.

Authors:  T Iwai; Y Muro; K Sugimoto; Y Matsumoto; M Ohashi
Journal:  Clin Exp Immunol       Date:  1996-08       Impact factor: 4.330

7.  Human anti-centromere sera recognise a 19.5 kD non-histone chromosomal protein from HeLa cells.

Authors:  H H Guldner; H J Lakomek; F A Bautz
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

8.  The Polycomb protein shares a homologous domain with a heterochromatin-associated protein of Drosophila.

Authors:  R Paro; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

9.  The chromo shadow domain, a second chromo domain in heterochromatin-binding protein 1, HP1.

Authors:  R Aasland; A F Stewart
Journal:  Nucleic Acids Res       Date:  1995-08-25       Impact factor: 16.971

Review 10.  Autoantibody-defined epitopes on nuclear antigens are conserved, conformation-dependent and active site regions.

Authors:  E M Tan; Y Muro; K M Pollard
Journal:  Clin Exp Rheumatol       Date:  1994 Nov-Dec       Impact factor: 4.473

View more
  2 in total

1.  cDNA cloning of a novel autoantigen targeted by a minor subset of anti-centromere antibodies.

Authors:  Y Muro; T Yamada; M Himeno; K Sugimoto
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.

Authors:  Rudolf Mierau; Pia Moinzadeh; Gabriela Riemekasten; Inga Melchers; Michael Meurer; Frank Reichenberger; Michael Buslau; Margitta Worm; Norbert Blank; Rüdiger Hein; Ulf Müller-Ladner; Annegret Kuhn; Cord Sunderkötter; Aaron Juche; Christiane Pfeiffer; Christoph Fiehn; Michael Sticherling; Percy Lehmann; Rudolf Stadler; Eckhard Schulze-Lohoff; Cornelia Seitz; Ivan Foeldvari; Thomas Krieg; Ekkehard Genth; Nicolas Hunzelmann
Journal:  Arthritis Res Ther       Date:  2011-10-21       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.